Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: lavalamp who wrote (11033)	11/13/1997 2:29:00 PM
From: Henry Niman	Read Replies (1) \| Respond to of 32384

lavalamp, I think that the 20 day period has always been part of the terms of the call. This is from the March 10-K: "Any such Ligand common stock or Allergan common stock will be valued based upon the average of the closing prices for such stock for the 20 trading days immediately preceding the day prior to the closing date of the Stock Purchase Option. The Stock Purchase Option Exercise Price will be paid generally within 60 days after the date of exercise of the Stock Purchase Option."